scholarly journals Non-invasive 3D Optical Imaging of Tissue Microstructure and Microcirculations in Vivo

CLEO: 2014 ◽  
2014 ◽  
Author(s):  
Ruikang K. Wang ◽  
Woo June Choi
Sensors ◽  
2020 ◽  
Vol 20 (8) ◽  
pp. 2379 ◽  
Author(s):  
Guillermo Rus ◽  
Inas H. Faris ◽  
Jorge Torres ◽  
Antonio Callejas ◽  
Juan Melchor

The adoption of multiscale approaches by the biomechanical community has caused a major improvement in quality in the mechanical characterization of soft tissues. The recent developments in elastography techniques are enabling in vivo and non-invasive quantification of tissues’ mechanical properties. Elastic changes in a tissue are associated with a broad spectrum of pathologies, which stems from the tissue microstructure, histology and biochemistry. This knowledge is combined with research evidence to provide a powerful diagnostic range of highly prevalent pathologies, from birth and labor disorders (prematurity, induction failures, etc.), to solid tumors (e.g., prostate, cervix, breast, melanoma) and liver fibrosis, just to name a few. This review aims to elucidate the potential of viscous and nonlinear elastic parameters as conceivable diagnostic mechanical biomarkers. First, by providing an insight into the classic role of soft tissue microstructure in linear elasticity; secondly, by understanding how viscosity and nonlinearity could enhance the current diagnosis in elastography; and finally, by compounding preliminary investigations of those elastography parameters within different technologies. In conclusion, evidence of the diagnostic capability of elastic parameters beyond linear stiffness is gaining momentum as a result of the technological and imaging developments in the field of biomechanics.


Gene Therapy ◽  
2007 ◽  
Vol 14 (22) ◽  
pp. 1587-1593 ◽  
Author(s):  
V Josserand ◽  
I Texier-Nogues ◽  
P Huber ◽  
M-C Favrot ◽  
J-L Coll

2005 ◽  
Vol 12 (3) ◽  
pp. 313-323 ◽  
Author(s):  
Nicole Y. Morgan ◽  
Sean English ◽  
Wei Chen ◽  
Victor Chernomordik ◽  
Angelo Russo ◽  
...  

2002 ◽  
Vol 1 (6) ◽  
pp. 419-422 ◽  
Author(s):  
Daniel C. Sullivan

Advances in genomics, proteomics and technology are changing medicine in fundamental ways. There are increasing clinical and laboratory requirements to obtain cellular and molecular information in vivo. This is particularly true in oncology, where the behavior of tumor cells is inextricably linked to their milieu. If cancer cells are removed from their microenvironment, their pattern of gene expression changes. Therefore, non-invasive, quantitative means of detecting gene and protein activity are essential. In vivo imaging is one methodology for achieving this. Marked advances in tracer methods for PET scanning or single-photon nuclear medicine techniques have occurred in the past few years. MRI contrast agents that reflect physiologic information are also being developed, although larger mass quantities of injectable material are required. The useful concept of “activatable agents” was pioneered in MRI. Similarly, ultrasound and computed tomography are being re-engineered to reflect information at the cellular level. In vivo optical imaging technologies have matured to the point where they are indispensable laboratory tools for small animal imaging. Human applications are in the feasibility testing stage, and the future for clinical optical imaging techniques looks bright. Merging these molecular imaging techniques with minimally or non-invasive image-guided therapeutic delivery techniques is a subsequent goal in the fight against cancer.


Sign in / Sign up

Export Citation Format

Share Document